Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
$0.59
-0.3%
$0.67
$0.53
$2.21
$5.42M1.91652,706 shs78,290 shs
Optec International, Inc. stock logo
OPTI
Optec International
$0.00
$0.00
$0.00
$0.00
$17KN/A996,882 shs1.62 million shs
TRX Gold Co. stock logo
TRX
TRX Gold
$0.34
+1.2%
$0.33
$0.27
$0.45
$96.21M0.24428,613 shs636,299 shs
Virios Therapeutics, Inc. stock logo
VIRI
Virios Therapeutics
$4.76
-4.6%
$4.98
$0.13
$1.04
$2.99M1.581.05 million shs31,531 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
0.00%-1.97%-14.75%-9.51%+58,819,900.00%
Optec International, Inc. stock logo
OPTI
Optec International
0.00%+15.38%-16.67%-42.31%+50.00%
TRX Gold Co. stock logo
TRX
TRX Gold
0.00%+1.22%+0.15%+13.37%-21.80%
Virios Therapeutics, Inc. stock logo
VIRI
Virios Therapeutics
-4.61%-0.83%-1.24%+59.20%+1,752.14%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
2.0686 of 5 stars
3.53.00.00.02.00.00.6
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/AN/AN/AN/A
TRX Gold Co. stock logo
TRX
TRX Gold
1.9898 of 5 stars
3.50.00.00.00.60.01.9
Virios Therapeutics, Inc. stock logo
VIRI
Virios Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
3.00
Buy$5.00750.05% Upside
Optec International, Inc. stock logo
OPTI
Optec International
0.00
N/AN/AN/A
TRX Gold Co. stock logo
TRX
TRX Gold
3.00
Buy$1.50341.05% Upside
Virios Therapeutics, Inc. stock logo
VIRI
Virios Therapeutics
2.00
Hold$5.005.04% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
$7.76M0.70N/AN/A$0.36 per share1.63
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/AN/A
TRX Gold Co. stock logo
TRX
TRX Gold
$45.41M2.12$0.00 per share173.35$0.24 per share1.42
Virios Therapeutics, Inc. stock logo
VIRI
Virios Therapeutics
N/AN/AN/AN/A$0.20 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
-$4.37M-$0.56N/AN/AN/A-53.20%-181.28%-50.88%8/13/2025 (Estimated)
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/A0.00N/AN/AN/AN/AN/A
TRX Gold Co. stock logo
TRX
TRX Gold
-$470K-$0.01N/A5.67N/A6.11%2.21%1.51%N/A
Virios Therapeutics, Inc. stock logo
VIRI
Virios Therapeutics
-$5.30M-$0.27N/AN/AN/AN/A-130.33%-115.00%8/6/2025 (Estimated)

Latest ASNS, OPTI, VIRI, HVO, and TRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
-$0.25-$0.22+$0.03-$0.22$1.20 million$0.72 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
N/AN/AN/AN/AN/A
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/AN/AN/A
TRX Gold Co. stock logo
TRX
TRX Gold
N/AN/AN/AN/AN/A
Virios Therapeutics, Inc. stock logo
VIRI
Virios Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
0.06
1.56
0.89
Optec International, Inc. stock logo
OPTI
Optec International
N/AN/AN/A
TRX Gold Co. stock logo
TRX
TRX Gold
0.03
0.83
0.51
Virios Therapeutics, Inc. stock logo
VIRI
Virios Therapeutics
N/A
7.27
7.27

Institutional Ownership

CompanyInstitutional Ownership
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
12.43%
Optec International, Inc. stock logo
OPTI
Optec International
N/A
TRX Gold Co. stock logo
TRX
TRX Gold
1.06%
Virios Therapeutics, Inc. stock logo
VIRI
Virios Therapeutics
9.05%

Insider Ownership

CompanyInsider Ownership
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
2.90%
Optec International, Inc. stock logo
OPTI
Optec International
50.34%
TRX Gold Co. stock logo
TRX
TRX Gold
2.25%
Virios Therapeutics, Inc. stock logo
VIRI
Virios Therapeutics
12.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Actelis Networks, Inc. stock logo
ASNS
Actelis Networks
409.21 million8.95 millionN/A
Optec International, Inc. stock logo
OPTI
Optec International
111.65 millionN/ANot Optionable
TRX Gold Co. stock logo
TRX
TRX Gold
120282.88 million275.50 millionOptionable
Virios Therapeutics, Inc. stock logo
VIRI
Virios Therapeutics
519.26 million16.91 millionOptionable

Recent News About These Companies

Dogwood Therapeutics Inc (DWTX)
Dogwood prices 578,950 shares at $8.26 in registered direct offering
Dogwood announces conversion of existing $19.5M in debt to equity
DWTX Stock trading resumes
Dogwood Therapeutics, Inc. (DWTX)
DWTX Stock trading halted, volatility trading pause
Dogwood announces first patient dosed in Phase 2b trial on Halneuron
Dogwood Therapeutics faces potential Nasdaq delisting
Dogwood says low-dose IMC-2 treatment reduces long-COVID fatigue
DWTX: Phase 2 Long COVID Results Expected Soon
Dogwood Therapeutics Reports Q3 2024 Financial Results
Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Actelis Networks stock logo

Actelis Networks NASDAQ:ASNS

$0.59 0.00 (-0.32%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$0.60 +0.01 (+1.16%)
As of 07/11/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Actelis Networks, Inc. engages in the design, development, manufacture, and marketing of cyber hardened, hybrid fiber, networking solutions for Internet of Things and telecommunication companies in North America, Europe, the Middle East, Israel, and the Asia Pacific. It provides rapid-deployment networking solutions for wide-area IoT applications, including federal, state, and local governments; intelligent traffic systems; and military, utility, rail, telecom, and campus applications. The company's products include ethernet access devices; network aggregator switches; and Advanced MetaLIGHT/ Gigaline element management systems software, which enables remote management, monitoring, maintenance, and configuration of the installed equipment in the network. It also offers dynamic spectral software; and access broadband equipment. It serves offers its products through system integrators, distributors, contractors, resellers, and consultants. The company was incorporated in 1998 and is headquartered in Fremont, California.

Optec International stock logo

Optec International OTCMKTS:OPTI

$0.0015 0.00 (0.00%)
As of 07/11/2025 03:49 PM Eastern

Optec International, Inc. engages in selling and marketing optimized fuel maximizer units in North America and internationally. It markets optimized fuel maximizer for passenger vehicles, intermediate/medium duty trucks, off-road equipment, generator systems, heavy duty diesel on-road vehicles, and transportation refrigeration units. The company was formerly known as Green Meadow Products, Inc. and changed its name to Optec International, Inc. in August 2017. Optec International, Inc. was founded in 2012 and is based in Carlsbad, California.

TRX Gold stock logo

TRX Gold NYSE:TRX

$0.34 +0.00 (+1.16%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$0.34 +0.00 (+0.26%)
As of 07/11/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TRX Gold Corporation engages in the exploration, development, and production of mineral property interests in the United Republic of Tanzania. The company primarily explores for gold deposits. It holds interests in the Buckreef gold project that comprises a single Special Mining License covering an area of 16.04 square kilometers and 12 Prospecting Licenses covering 98.19 square kilometers located in north-central Tanzania. The company was formerly known as Tanzanian Gold Corporation and changed its name to TRX Gold Corporation in May 2022. TRX Gold Corporation was incorporated in 1990 and is based in Oakville, Canada.

Virios Therapeutics stock logo

Virios Therapeutics NASDAQ:VIRI

$4.76 -0.23 (-4.61%)
As of 07/11/2025

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.